Zurueck zur Suche

Reporte zur Charge U019289

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CO 3 NY 2 ID 1 OR 1 VA 1

VAERS 2579646

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
-
Alter
5,0
Geschlecht
F
Eingang
10.02.2023
Impfdatum
10.02.2023
Beginn
10.02.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

I had drawn up the vaccine and administered it. I was putting the data in the system and did not realize the vaccines expiration date was 12/15/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2449430

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
NY
Alter
4,0
Geschlecht
M
Eingang
17.09.2022
Impfdatum
14.04.2022
Beginn
14.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No other AE; Caller is a nurse who reports that PROQUAD and VARIVAX may have been given after a temperature excursion that occurred in April 2022. Vaccines were then sent back to the agency so she does not have time/temperature data and does not know whether any vac; This spontaneous report was received from a registered nurse and refers to a 4-year-old male patient. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided. On 14-APR-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot #U019289, expiration date: 15-DEC-2022, administered subcutaneously in the right deltoid for prophylaxis (product storage error), it was mentioned that there was not previous temperature excursion. No additional adverse event was reported. This is one of four reports received from the same reporter.; Sender's Comments: US-009507513-2208USA009203: US-009507513-2209USA003333: US-009507513-2209USA003334:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2449378

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
NY
Alter
4,0
Geschlecht
F
Eingang
17.09.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Caller is a nurse who reports that PROQUAD and VARIVAX may have been given after a temperature excursion that occurred in April 2022. Vaccines were then sent back so she does not have time/temperature data and does not know whether any vac; This spontaneous report was received from a nurse and refers to an unknown number of patients of an unknown age and gender. The patient's medical history, concurrent conditions. concomitant therapies and previous drugs reactions or allergies were not reported. On an unknown date in 2022, the patients were vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) lot #W004694, expiration date: 08-AUG-2023, and lot # U019289 expiration date 15-DEC-2022 (vaccination scheme, dose description and route of administration were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX) lot #U030162, expiration date: 28-SEP-2023, administered for prophylaxis (vaccination scheme, dose description and route of administration were not provided) following a temperature excursion that occurred on an unknown date in April 2022 (product storage error), it was mentioned that there was not previous temperature excursion. No additional adverse event was reported. This is a non-valid case due ot lack o f patient's identifiers. Follow-up information has been received from a registered nurse on 07-SEP-2022 and patients' identifiers have been provided. The patient was a 4-year-old female. On 11-FEB-2022, the freezer temperature on the temperature tracker was noted to be out of range and on 21-APR-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # U019289 subcutaneously in the left thigh for prophylaxis. There were no previous doses reported. This is one of four reports received from the same reporter.; Sender's Comments: US-009507513-2209USA003332: US-009507513-2209USA003333: US-009507513-2209USA003334: US-009507513-2209USA003333: US-009507513-2209USA003332:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2266747

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
ID
Alter
14,0
Geschlecht
F
Eingang
07.05.2022
Impfdatum
18.04.2022
Beginn
18.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE details provided; Medical assistant calling would like to know if PROQUAD administered to a 14 year old counts as a valid dose.; This spontaneous report was received from a medical assistant and refers to a 14-year-old female patient. The patient's concomitant medications included hepatitis a vaccine inact (HAVRIX) and polio vaccine inact 3v (vero) (IPOL POLIO VACCINE). Concurrent conditions, pertinent medical history and drug reactions or allergies were not reported. On 18-APR-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection, administered subcutaneously in the left arm, lot # U019289 was confirmed to be valid, expiration date 15-DEC-2022 (strength and exact dose not reported) for prophylaxis (product administered to patient of inappropriate age). No additional adverse event details provided (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2164886

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
OR
Alter
4,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product expiration date issue Product lot number issue

Symptomtext

No additional AEs reported; She stated that a consumer made her aware that a vial of PROQUAD was found missing the lot and expiration.; She stated that a consumer made her aware that a vial of PROQUAD was found missing the lot and expiration.; an AE is being filed since a PQC product was administered to a patient; This spontaneous report has been received from a registered nurse via a company representative concerning to a 4-year old male patient. Patient's concurrent conditions, medical history and concomitant medications were not provided. On 15-FEB-2022 the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) 0.5 milliliter, (lot number U019289, expiration date: 15-DEC-2022) (strength, route of administration, were not provided) for prophylaxis. However, the patient made the reporter aware that the vial of the vaccines had missing the lot and expiration numbers in the carton (product lot number issue, product expiration date issue) but the carton did not present any damage. The label was intact, there were no other printing issues, the label did not look like was exposed to moisture or increased humidity. Nevertheless, the missing information the vial appeared normal. It was reported that, the vaccine was administered after the missing information was discovered (poor quality product administered). Additionally, the carton appeared normal and was not damaged, the other vials in the carton appeared normal and had the lot and expiration date printed on the vials.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1943072

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
13.12.2021
Impfdatum
23.11.2021
Beginn
23.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no other issues; incorrect storage PROQUAD was administered; This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On 23-NOV-2021, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # U019289 exp date 15-DEC-2022) (dose and route not reported) that was exposed to a temperature excursion of 29.9 F for a time frame of 3 hours and 2 minutes. The maximum temperature was -1.6 ?C and had not back in range at the time of the report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1903497

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
27.11.2021
Impfdatum
05.11.2021
Beginn
05.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; temperature excursion; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 05-NOV-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rha) (PROQUAD) lot # U019289, expiration date 15-DEC-2022, at a dose of 0.5 milliliter for prophylaxis (vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). No other adverse event reported. The vaccine was stored in a temperature of 20 degree Fahrenheit for 17 (unspecified time unit). There was no previous temperature excursion reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1903496

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
27.11.2021
Impfdatum
05.11.2021
Beginn
05.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; temperature excursion; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 05-NOV-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rha) (PROQUAD) lot # U019289, expiration date 15-DEC-2022, at a dose of 0.5 milliliter for prophylaxis (vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). No other adverse event reported. The vaccine was stored in a temperature of 20 degree Fahrenheit for 17 (unspecified time unit). There was no previous temperature excursion reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1903495

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019289

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
27.11.2021
Impfdatum
05.11.2021
Beginn
05.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; temperature excursion; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 05-NOV-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rha) (PROQUAD) lot # U019289, expiration date 15-DEC-2022, at a dose of 0.5 milliliter for prophylaxis (vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). No other adverse event reported. The vaccine was stored in a temperature of 20 degree Fahrenheit for 17 (unspecified time unit). There was no previous temperature excursion reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-